Kyle Carver

Insider Reports History

Location
New York, NY
Signature
/s/ Gregory S. Moss, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kyle Carver:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Evommune, Inc. Chief Financial Officer Common Stock 62.5K $1.12M $17.84 09 Dec 2025 Direct
Evommune, Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 279K 05 Nov 2025 Direct
Evommune, Inc. Chief Financial Officer Series B Preferred Stock 0 07 Nov 2025 Direct
Kadmon Holdings, Inc. SVP, CAO, Controller Common Stock 0 $9.50 09 Nov 2021 Direct
Kadmon Holdings, Inc. SVP, CAO, Controller Stock Option (right to buy) 0 $5.54 09 Nov 2021 Direct

Insider Reports Filed by Kyle Carver

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EVMN Evommune, Inc. 09 Dec 2025 1 -$237K 4 11 Dec 2025 Chief Financial Officer
EVMN Evommune, Inc. 07 Nov 2025 2 $0 4 12 Nov 2025 Chief Financial Officer
EVMN Evommune, Inc. 05 Nov 2025 1 $0 4 07 Nov 2025 Chief Financial Officer
EVMN Evommune, Inc. 05 Nov 2025 0 $0 3 05 Nov 2025 Chief Financial Officer
KDMN Kadmon Holdings, Inc. 09 Nov 2021 6 -$2.52M 4 09 Nov 2021 SVP, CAO, Controller